Acquisition by Arbel Irit of 30666 shares of Brainstorm Cell subject to Rule 16b-3
BCLI Stock | USD 1.89 0.10 5.03% |
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
Brainstorm |
Filed transaction by Brainstorm Cell Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Brainstorm Cell Fundamental Analysis
We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Brainstorm Cell is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Brainstorm Cell Ther Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.
Peers
Brainstorm Cell Related Equities
XFOR | X4 Pharmaceuticals | 10.87 | ||||
GBIO | Generation Bio | 6.74 | ||||
CRVS | Corvus Pharmaceuticals | 5.92 | ||||
HCWB | HCW Biologics | 2.78 | ||||
CUE | Cue Biopharma | 2.34 | ||||
PLX | Protalix Biotherapeutics | 2.30 | ||||
BCAB | Bioatla | 2.08 | ||||
CCCC | C4 Therapeutics | 2.07 | ||||
PASG | Passage Bio | 1.69 | ||||
ANTX | AN2 Therapeutics | 1.60 | ||||
GRI | GRI Bio | 1.41 | ||||
ALDX | Aldeyra | 1.26 | ||||
DAWN | Day One | 1.13 | ||||
CNTB | Connect Biopharma | 0.96 | ||||
TRVI | Trevi Therapeutics | 0.53 | ||||
HOWL | Werewolf Therapeutics | 0.75 | ||||
MREO | Mereo BioPharma | 1.38 | ||||
INZY | Inozyme Pharma | 1.45 | ||||
TERN | Terns Pharmaceuticals | 1.56 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
CELC | Celcuity LLC | 2.84 | ||||
CKPT | Checkpoint Therapeutics | 4.50 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |